International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

PostScription: Stopping Drug Reps at the Door

Author(s): Brewer Benjamin

Issue: Jan/Feb 2006 - Sports Medicine
View All Articles in Issue

Page(s): 80

PostScription: Stopping Drug Reps at the Door Page 1

Download in electronic PDF format for $75

Abstract:

Related Keywords: ethics, pharmaceutical industry

Related Categories: PROFESSIONAL ISSUES

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
PostScription: Stopping Drug Reps at the Door Brewer Benjamin	Jan/Feb 2006 Pg. 80
The Relevance of the Soviet Pharmaceutical Industry and Dispensing: Dependence on Traditional Compounding Conroy Mary Schaeffer	Mar/Apr 2011 Pg. 117-122
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A	Nov/Dec 2011 Pg. 526-527
PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare Allen Loyd V Jr, Williams LaVonn A	Jul/Aug 2012 Pg. 350-351
PostScription: The Fourth Annual Student Pharmacist Compounding Competition: Building Future Leaders in the Industry Bastos Dea	May/Jun 2014 Pg. 262-263
Local Ventilation for Safe Containment in the Pharmaceutical Industry Walters Douglas B, Ryan Ray	Jul/Aug 2005 Pg. 293-298
Cellulose Applications for the Pharmaceutical Industry Nicoll Harold	May/Jun 2000 Pg. 196-197
International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance Miller David G	Nov/Dec 2015 Pg. 449-450
PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry" Allen Loyd V Jr	Mar/Apr 2022 Pg. 92
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective Timko Robert J, Crooker Philip EM	Mar/Apr 2014 Pg. 101-111
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 Allen Loyd V Jr	Jul/Aug 2007 Pg. 350-351
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Dillon L R	Jan/Feb 2020 Pg. 30-36
PostScription: Responsibilities of a Compounding Pharmacist Allen Loyd V Jr	Jul/Aug 2014 Pg. 351
PostScription: Compounding Seminar: International Pharmaceutical Federation Congress--Istanbul Padilla Rafael	Nov/Dec 2009 Pg. 574
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2 Allen Loyd V Jr	Sep/Oct 2007 Pg. 438-439
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Lyon Joanna	Nov/Dec 2012 Pg. 456-460
Allowing Compounding Pharmacies to Address Drug Shortages Broughel James	Mar/Apr 2022 Pg. 100-109
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun	Mar/Apr 2018 Pg. 108-121
Does Your Drug Expertise Include Clinical Pharmaceutics? Newton David W	May/Jun 2016 Pg. 202-206
Return to Top